Aminoethyl-isothiourea inhibits the increase in plasma endothelin-1 caused by serogroup a streptococci and prolongs survival in rat peritoneal sepsis

Shock

Volumn 15, Issue 6, 2001, Pages 446-452

  Saetre, Torunn ^a,c   Höiby, E Arne ^b   Aspelin, Trude ^a   Lermark, Gro ^b   Egeland, Thore ^c   Svindland, Aud ^a   Lyberg, Torstein ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Nitric oxide synthase inhibition; Reactive oxygen species; Septic shock

Indexed keywords

AMINOETHYL ISOTHIOUREA; AMINOETHYL-ISOTHIOUREA; ANTIHYPERTENSIVE AGENT; BOSENTAN; DRUG DERIVATIVE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; SULFONAMIDE; THIOUREA;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; MALE; RAT; SEPTIC SHOCK; SPRAGUE DAWLEY RAT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SURVIVAL RATE; TIME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ENDOTHELIN-1; ENZYME INHIBITORS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SULFONAMIDES; SURVIVAL RATE; THIOUREA; TIME FACTORS;

EID: 0035380116     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115060-00006     Document Type: Article

References (41)

1. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638-1652, 1995.
2. Brun-Buisson C, Doyon F, Carlet J: Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 154:617-624, 1996.
3. Hoiby EA, Hasseltvedt V, Sollid K, Lermark G: Increased incidence of severe group A streptococcal infections in Norway 1993-1994: some obstetric aspects. J Obstet Gynaecol 14:S92-S98, 1994.
4. Stevens DL: The flesh-eating bacterium: what's next? J Infect Dis 179(Suppl 2):S366-S374, 1999.
5. Bone RC: How gram-positive organisms cause sepsis. J Crit Care 8:51-59, 1993.
6. Curtis N: Invasive group A streptococcal infection. Curr Opin Infect Dis 9:191-202, 1996.
7. Muller-Alouf H, Alouf JE, Gerlach D, Ozegowski JH, Fitting C, Cavaillon JM: Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immunol 62: 4915-4921, 1994.
8. Thiemermann C: Nitric oxide and septic shock. Gen Pharmacol 29:159-166, 1997.
9. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
10. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
11. Kubes P, Granger DN: Nitric oxide modulates microvascular permeability. Am J Physiol 262:H611-H615, 1992.
12. Southan GJ, Szabo C, Thiemermann C: Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114:510-516, 1995.
13. Thiemermann C, Ruetten H, Wu CC, Vane JR: The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116:2845-2851, 1995.
14. Saetre T, Gundersen Y, Thiemermann C, Lilleaasen P, Aasen AO: Aminoethylisothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 9:109-115, 1998.
15. De Kimpe SJ, Hunter ML, Bryant CE, Thiemermann C, Vane JR: Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats. Br J Pharmacol 114: 1317-1323, 1995.
16. Sriskandan S, Moyes D, Buttery LK, Wilkinson J, Evans TJ, Polak J, Cohen J: The role of nitric oxide in experimental murine sepsis due to pyrogenic exotoxin A-producing Streptococcus pyogenes. Infect Immunol 65:1767-1772, 1997.
17. Goode HF, Webster NR: Free radicals and antioxidants in sepsis. Crit Care Med 21:1770-1776, 1993.
18. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424-C1437, 1996.
19. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993.
20. Yanagisawa M, Masaki T: Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 10:374-378, 1989.
21. Battistini B, Forget MA, Laight D: Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 5:167-183, 1996.
22. Weitzberg E, Lundberg JM, Rudehill A: Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33:222-227, 1991.
23. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797-9800, 1988.
24. Clozel M, Breu V, Gray GA, Kalina B, Loffler BM, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W: Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 270:228-235, 1994.
25. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG: A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214: 11-16, 1993.
26. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:682-685, 1990.
27. Ruetten H, Thiemermann C: Prevention of the expression of inducible nitric oxide synthase by aminoguanidine or aminoethyl-isothiourea in macrophages and in the rat. Biochem Biophys Res Commun 225:525-530, 1996.
28. Sriskandan S, Moyes D, Buttery LK, Krausz T, Evans TJ, Polak J, Cohen J: Streptococcal pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multi-organ failure due to Streptococcus pyogenes. J Infect Dis 173:1399-1407, 1996.
29. Bucher A, Martin PR, Hoiby EA, Halstensen A, Odegaard A, Hellum KB, Westlie L, Hallan S: Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988. Eur J Clin Microbiol Infect Dis 11:416-426, 1992.
30. Saetre T, Hoiby EA, Aspelin T, Lermark G, Egeland T, Lyberg T. Aminoethyl-isothiourea (AE-ITU), a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Crit Care Med 28(8):2697-2706, 2000.
31. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
32. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP: A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two non-selective strategies. Shock 5: 116-121, 1996.
33. Wray GM, Millar CG, Hinds CJ, Thiemermann C: Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 9:329-335, 1998.
34. Leach M, Frank S, Olbrich A, Pfeilschifter J, Thiemermann C: Decline in the expression of copper/zinc superoxide dismutase in the kidney of rats with endotoxic shock: effects of the superoxide anion radical scavenger, tempol, on organ injury. Br J Pharmacol 125:817-825, 1998.
35. Doherty D, Shapira R, Burnett WJ: Synthesis of aminoalkylisothiouronium salts and their conversion to mercaptoalkylguanidines and thiazolines. J Am Chem Soc 79:5667-5671, 1957.
36. Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R: Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 272:9030-9036, 1997.
37. Shapira R, Doherty D, Burnett WJ: Chemical protection against ionizing radiation. Radiat Res 7:22-34, 1957.
38. Millar CG, Thiemermann C: Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol 121:1824-1830, 1997.
39. Ruetten H, Thiemermann C, Vane JR: Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Br J Pharmacol 118:98-204, 1996.
40. Weitzberg E, Hemsen A, Rudehill A, Modin A, Wanecek M, Lundberg JM: Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol 118:617-626, 1996.
41. Mitaka C, Hirata Y, Yokoyama K, Nagura T, Tsunoda Y, Amaha K: Improvement of renal dysfunction in dogs with endotoxemia by a non-selective endothelin receptor antagonist. Crit Care Med 27:146-153, 1999.